It is becoming increasingly recognized that people with COPD have an elevated risk of serious CV events,1 discussed Hanania ...

The FDA recently approved mepolizumab for treating adults with inadequately controlled COPD and an eosinophilic phenotype, ...

Chronic obstructive pulmonary disease (COPD) can be treated with lifestyle changes, prescription medications, and specialist ...

In smokers with COPD, LABA+LAMA is more effective than LABA+ICS in preventing exacerbations, regardless of blood eosinophil count.

EU is first to approve Sanofi and Regeneron's Dupixent for COPD, ending a 10-year hiatus in new therapies. ... the recommended treatment for COPD in Europe is an inhaled corticosteroid (ICS), ...